Skip to content

13F-HR filed by Valence8 US LP

Valence8 US LP filed this 13F-HR for the quarter ended 2024-09-30, filed 2024-11-12, with 62 holding rows worth $241,102,218.

Accession
0001172661-24-004545
Filed
2024-11-12
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2024

A holdings report, 62 entries on the cover page, a total value of $241,102,218 stated on the cover page (in dollars after the unit check, H1), rows summing to $241,102,218 with VALUE read as dollars as filed, 13F file number 028-22775. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ISHARES MSCI USA QUALITY FACTOR ETF46432F339ETF337,472$60,508,730dollars as filed
INVESCO QQQ TR46090E103COM88,149$43,022,882dollars as filed
ISHARES TR46434V456MSCI INTL QUALTY1,026,290$42,580,772dollars as filed
iShares MSCI EAFE Value ETF464288877SHS399,186$22,965,171dollars as filed
Vanguard Value ETF922908744SHS96,630$16,868,699dollars as filed
SELECT SECTOR SPDR TR81369Y308STATE STREET CON165,267$13,717,161dollars as filed
ISHARES TR MSCI UK ETF NEW46435G334MSCI UK ETF NEW209,344$7,831,559dollars as filed
iShares MSCI Japan ETF46434G822SHS108,634$7,771,676dollars as filed
ASTRAZENECA PLC SPONSORED ADR046353108ADR64,000$4,986,240dollars as filedcall
Utilities Select Sector SPDR Fund81369Y886SHS51,940$4,195,713dollars as filed
JAZZ PHARMACEUTICALS PLC SHS USDG50871105Stock8,969$999,236dollars as filed
Bristol-Myers Squibb Company110122108COM17,785$920,196dollars as filed
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR4,585$684,586dollars as filed
Amgen Inc.031162100COM2,000$644,420dollars as filedput
Amgen Inc.031162100COM2,000$644,420dollars as filedcall
SOLENO THERAPEUTICS INC834203309COM12,500$631,125dollars as filedcall
CRISPR THERAPEUTICS AG NAMEN AKTH17182108Stock13,100$615,438dollars as filedcall
INSMED INC COM PAR $.01457669307Stock7,865$574,145dollars as filed
Indivior PLCG4766E116Common Stock57,293$564,186dollars as filed
Eli Lilly and Company532457108COM633$560,800dollars as filed
ARGENX SE SPONSORED ADR04016X101ADR953$516,602dollars as filed
SOLENO THERAPEUTICS INC834203309COM9,706$490,056dollars as filed
INSMED INC COM PAR $.01457669307Stock6,600$481,800dollars as filedcall
KEROS THERAPEUTICS INC COM492327101Stock8,025$466,012dollars as filed
NOVO-NORDISK A S ADR670100205ADR3,900$464,373dollars as filedcall
NUVALENT INC COM670703107Stock4,115$420,965dollars as filed
FILANA THERAPEUTICS INC14817C107CMN14,100$414,963dollars as filedput
ULTRAGENYX PHARMACEUTICAL IN90400D108COM6,900$383,295dollars as filedcall
APELLIS PHARMACEUTICALS INC03753U106COM13,100$377,804dollars as filedcall
JANUX THERAPEUTICS INC47103J105COM7,857$356,944dollars as filed
AVADEL PHARMACEUTICALS PLCG29687103COM SHS26,200$343,613dollars as filedcall
CRINETICS PHARMACEUTICALS INC COM22663K107Stock6,684$341,552dollars as filed
TYRA BIOSCIENCES INC90240B106COMMON STOCK13,188$310,050dollars as filed
APOGEE THERAPEUTICS INC COM03770N101Stock5,240$307,798dollars as filed
VIRIDIAN THERAPEUTICS INC92790C104COM13,100$298,025dollars as filedcall
VAXCYTE INC COM92243G108Stock2,468$282,018dollars as filed
MODERNA INC60770K107COM4,100$274,003dollars as filedcall
INTELLIA THERAPEUTICS INC45826J105COM13,020$267,561dollars as filed
VIR BIOTECHNOLOGY INC92764N102COM33,650$252,039dollars as filed
BLUEPRINT MEDICINES CORP09627Y109COM2,618$242,165dollars as filed
ULTRAGENYX PHARMACEUTICAL IN90400D108COM4,241$235,588dollars as filed
CELLDEX THERAPEUTICS INC NEW15117B202COM NEW6,500$220,935dollars as filedput
ENANTA PHARMACEUTICALS INC29251M106COM19,939$206,568dollars as filed
RELAY THERAPEUTICS INC COM75943R102Stock26,200$185,496dollars as filed
Applied Therapeutics Inc03828A101Common Stock20,300$172,550dollars as filedcall
ALTIMMUNE INC02155H200COM NEW26,200$160,868dollars as filedcall
ZEVRA THERAPEUTICS INC COM NEW488445206Stock21,596$149,876dollars as filed
ALTIMMUNE INC02155H200COM NEW23,500$144,290dollars as filedput
ERASCA INC COM29479A108Stock46,923$128,100dollars as filed
IOVANCE BIOTHERAPEUTICS INC462260100COM13,100$123,009dollars as filedcall
SOLID BIOSCIENCES INC83422E204COMMON STOCK15,728$109,624dollars as filed
JANUX THERAPEUTICS INC47103J105COM2,300$104,489dollars as filedput
VISTAGEN THERAPEUTICS INC92840H400COM34,376$103,472dollars as filed
BIOCRYST PHARMACEUTICALS INC COM09058V103Stock13,100$99,560dollars as filedcall
ZURA BIO LTDG9TY5A101COMMON STOCK17,495$71,030dollars as filed
ALECTOR INC014442107COMMON STOCK14,708$68,539dollars as filed
CLIMB BIO INC28658R106COMMON STOCK12,045$61,309dollars as filed
C4 THERAPEUTICS INC12529R107COM STK10,500$59,850dollars as filedcall
CYPHERPUNK TECHNOLOGIES INC52187K200COM NEW18,511$47,573dollars as filed
NEKTAR THERAPEUTICS640268108COM26,107$33,939dollars as filed
GOSSAMER BIO INC COM38341P102Stock20,700$20,418dollars as filedcall
KEZAR LIFE SCIENCES INC49372L100COM21,136$16,342dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001172661-24-004545this filing2024-11-12acceptance time not in the bulk data set